CDR Health, the provider of Florida’s monoclonal antibody treatment centers, announced on Friday that its therapy sites will close this week, citing a lack of federal funding.

The closures come just a week after CDR Health began shuttering their Covid-19 testing sites. Since the beginning of the pandemic, CDR Health reports they have provided over 4 million Covid-19 tests, 2.7 million vaccinations, and 150,000 monoclonal antibody treatments.

“I am extremely proud of the CDR team, who has worked tirelessly since March 2020 to rapidly adapt to meet these healthcare challenges by combating the impact of COVID-19 on our communities in Florida,” said CDR Health CEO Tina Vidal-Duart in a statement

The company says that if new federal funding reemerges, the possibility of reopening treatment sites may be on the table. New Department of Health data, however, shows that a reimplementation of sites may not be necessary.

Data posted Thursday showed fewer than 1,300 Florida hospital inpatients had COVID-19, continuing a steady decrease. The data said a reported 1,277 inpatients had COVID-19, down from 1,529 a week earlier. Also, the data said 148 COVID-19 patients were in intensive-care units, down from 227 a week earlier. After a surge in cases and hospitalizations in December and January because of the highly contagious Omicron variant of the coronavirus, the numbers have steadily declined in February and March.

Gov. Ron DeSantis has championed the notion of having the choice of seeking monoclonal antibody therapy, going to battle with the Biden administration over the state’s ability to host treatment centers. In January, the U.S. Food and Drug Administration (FDA) severely restricted the use and dispersing of monoclonal antibody treatments for COVID-19, claiming that they are ineffective against the Omicron strain of the virus.

“Without a shred of clinical data to support this action, Biden has forced trained medical professionals to choose between treating their patients or breaking the law,” said DeSantis. “This indefensible edict takes treatment out of the hands of medical professionals and will cost some Americans their lives. There are real-world implications to Biden’s medical authoritarianism  – Americans’ access to treatments is now subject to the whims of a failing president.”

The FDA’s action left more than 2,000 Floridians reeling, as their appointment for treatment was abruptly canceled by the federal government at the height of the Omicron wave.

“As a result of this abrupt and clinically unsupported action, the appointments for more than 2,000 Floridians to receive this treatment were canceled on January 25, 2022, alone. This decision was made solely by Biden’s Food and Drug Administration (FDA) without advance warning to states or health providers and without clinical data to support the decision,” continued the governor. “The deliberate decision by the Biden Administration to make this announcement effective immediately, through a press release, actively prevents states and health care providers from making real-time operational decisions that save lives.”